Pfizer raises future profit forecast

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Pfizer raised its 2025 profit forecast on strong Vyndaqel and Eliquis demand, despite a 20 cent a share charge from a cancer drug deal with China's 3SBio.
Back to articles

Actual Topics

Wed, 06 Aug 2025 06:30:05 GMT

Intel struggles on chip quality

Intel's key 18A chip tech faces quality issues, risking its plan to rival TSMC and boost U.S. chipmaking despite heavy investment in factories and R&D.

Tue, 05 Aug 2025 21:30:04 GMT

Palantir beats revenue estimates

Palantir topped $1B in Q2 revenue for the first time, beating estimates. EPS hit 16 cents per share.

Subscribe to "Fundamental Analysis" feed

订阅
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台，SWFX和其它相关交易详情，
请致电我们或要求回电。
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
欲了解更多有关杜高斯贝银行差价合约/外汇交易平台，SWFX和其它相关交易详情，
请致电我们或要求回电。
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.